1[1]Spivak J L, Phanm J, lsaac M, et al. Erythropoietin is both a mitogen and survival factor. Blood, 1991, 77:1228-1232.
2[2]Phillip K, Eugene C. Erythropoietin radioinnunoassy in evaluating patients with polycythemia. Ann lnt Med, 1998, 94:44-48.
3[3]RemchaAF, Montserrat 1, Santamaria A, et al. Serum erythropoierin in the diagnosis of polycythemia vare. A follow-up study, Haematologica, 1997, 82: 406-408.
4[4]Dai CH, Krantza SB, Green WF, et al. Polycythemia vera burstforming usintserythroid response to stem cell factor and c-kit receptor expression. Br J Haemato, 1994, 86:12-15.
5[5]Correa PN, Eskinazi D, Axelrad AA, et al. Circulaing erythroid pro-genitor in polycythemia vera are hyper~nsitive to insulin-like growth factor in vitro: Studie in an improved serumfree medium. Blood,1994, 83:99-103.
6[6]Muta K, Krantz SB, Bondurant MC, et al. Distinct role of erythropoietin, insuli-like growth factor I and stem cell factor in development of erythroid. J Clin Invest, 1994, 94: 35-38.
7[7]Gruppo ltaliano Studio Policitemia. Ann Intern Med, 1995, 123: 656-660.
